Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ.
Journal: Oncoimmunology
Published: September 06, 2017
CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNγ with Dependency on Natural Killer Cells.
Journal: Frontiers in immunology
Published: September 04, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026